Cresset Asset Management LLC Has $3.34 Million Stock Holdings in Doximity, Inc. $DOCS

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Cresset Asset Management LLC decreased its holdings in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 11.2% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 57,505 shares of the company's stock after selling 7,227 shares during the period. Cresset Asset Management LLC's holdings in Doximity were worth $3,337,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of DOCS. VSM Wealth Advisory LLC bought a new stake in Doximity in the first quarter valued at approximately $29,000. Allworth Financial LP raised its stake in Doximity by 104.0% in the first quarter. Allworth Financial LP now owns 563 shares of the company's stock valued at $32,000 after buying an additional 287 shares during the period. National Bank of Canada FI bought a new stake in Doximity in the first quarter valued at approximately $33,000. Spire Wealth Management raised its stake in Doximity by 73.2% in the first quarter. Spire Wealth Management now owns 615 shares of the company's stock valued at $36,000 after buying an additional 260 shares during the period. Finally, Kapitalo Investimentos Ltda bought a new stake in Doximity in the fourth quarter valued at approximately $50,000. Institutional investors own 87.19% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. William Blair restated an "outperform" rating on shares of Doximity in a research note on Friday, May 16th. Wells Fargo & Company increased their target price on Doximity from $55.00 to $62.00 and gave the stock an "equal weight" rating in a research note on Monday, August 4th. The Goldman Sachs Group set a $50.00 target price on Doximity and gave the stock a "neutral" rating in a research note on Wednesday, May 21st. JPMorgan Chase & Co. lowered their target price on Doximity from $63.00 to $60.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 27th. Finally, Piper Sandler increased their target price on Doximity from $65.00 to $69.00 and gave the stock an "overweight" rating in a research note on Monday, August 11th. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and eleven have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $66.21.

Insider Buying and Selling

In related news, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the sale, the director owned 16,618 shares of the company's stock, valued at $948,721.62. This represents a 10.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Regina M. Benjamin sold 5,000 shares of the stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $63.00, for a total value of $315,000.00. Following the sale, the director directly owned 16,618 shares in the company, valued at $1,046,934. This represents a 23.13% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 36,000 shares of company stock valued at $2,140,940 over the last 90 days. 31.30% of the stock is owned by corporate insiders.

Doximity Price Performance

NASDAQ:DOCS traded up $3.5630 during trading hours on Friday, reaching $67.6930. 1,637,248 shares of the company were exchanged, compared to its average volume of 2,323,116. The company has a market capitalization of $12.68 billion, a P/E ratio of 67.69, a P/E/G ratio of 4.10 and a beta of 1.36. Doximity, Inc. has a 1-year low of $35.32 and a 1-year high of $85.21. The business has a 50 day moving average of $60.80 and a 200 day moving average of $60.49.

Doximity (NASDAQ:DOCS - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The firm's revenue for the quarter was up 15.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.28 EPS. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, equities research analysts anticipate that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.